Clinical trial

Comparison of Combination Therapy: Montelukast and Inhaled Steroid on Exercise…

NCT00462592 · Hamilton Health Sciences Corporation, Other · Completed

Key facts

NCT number NCT00462592
Title Comparison of Combination Therapy: Montelukast and Inhaled Steroid on Exercise Induced Bronchoconstriction
Official title A Randomised Double Blind, Placebo Controlled 4-way Cross Over Study Comparing Montelukast, Inhaled Budesonide and Their Combination on Exercise-induced Bronchoconstriction
Lead sponsor Hamilton Health Sciences Corporation, Other
Collaborators Merck Sharp & Dohme LLC Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Asthma
Intervention type Drug, Other
Interventions budesonide, montelukast, placebo
Enrollment 18
Start date Mar 1, 2007
Primary completion Jun 1, 2009
Completion Jun 1, 2009
First posted Apr 19, 2007
Last update posted Oct 21, 2009
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies